Related Experiment Video
Updated: May 30, 2026
05:51
Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells
Published on: June 15, 2013
Family interaction in pediatric diabetes
1Yale School of Nursing, New Haven, CT 06536, USA. sarah.jaser@yale.edu
Current Diabetes Reports
|August 20, 2011
Summary
Family support is key for youth adapting to type 1 diabetes. Warm, collaborative parental involvement, especially monitoring, improves outcomes during adolescence, but parents need support managing their own distress.
Area of Science:
- Pediatric Endocrinology
- Family Psychology
- Chronic Illness Management
Background:
- Adaptation to type 1 diabetes (T1D) is significantly influenced by family dynamics.
- Understanding family interactions is crucial for optimizing T1D management in youth.
- Existing literature highlights the need for a comprehensive view of family roles.
Purpose of the Study:
- To review and synthesize current literature on family interaction in youth with T1D.
- To identify recent advancements and key themes in the research on family involvement.
- To provide insights into effective family-based support strategies for T1D.
Main Methods:
- Literature review of studies on family interaction and T1D in pediatric populations.
- Analysis of recent advancements including parental involvement specificity, paternal roles, and parental distress.
- Inclusion of observational methods and cultural considerations.
Main Results:
- Increased specificity in defining types of parental involvement.
- Growing acknowledgment of the father's role and the impact of parental distress.
- Emphasis on observational methods and cultural context in family interactions.
Conclusions:
- Continued parental involvement, particularly monitoring, is vital for adolescents with T1D.
- Optimal outcomes are associated with warm, collaborative parental engagement.
- Supporting parents in managing their distress is essential for sustained, effective involvement.
Related Concept Videos
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...